About this course
Social Anxiety Disorder (SAD) is among the most common yet misunderstood anxiety disorders. Emerging research reveals that its core mechanism lies not merely in fear of negative evaluation but in self-focused attention and safety behaviors that maintain distorted self-imagery. This two-hour seminar integrates evidence-based cognitive-behavioral protocols, cutting-edge digital and virtual exposure tools, and pharmacologic insights to equip clinicians with strategies that deliver rapid, durable change. Participants will leave with concrete, measurement-based tools that can be implemented immediately in both individual and group settings.
Date: Thursday, February 5, 2026
Time: 6-8pm (EST)
CEUs: 2
Online via Zoom
Register
Learning Objectives
1. Diagnose Social Anxiety Disorder using DSM-5-TR criteria and validated scales.
2. Apply Clark & Wells and Heimberg CBT protocols with precision, including video feedback and attention retraining.
3. Design a stepwise exposure plan (in-vivo/VR) integrated with post-event processing interventions.
4. Select evidence-based pharmacologic and third-wave adjuncts to enhance treatment outcomes.
5. Incorporate emerging digital strategies (iCBT, VRET, ACT) within a measurement-based care model.
Intended Audience
Psychiatrists, psychologists, social workers, counselors, nurse practitioners, and other licensed mental health professionals providing care to adolescents and adults across outpatient, IOP/PHP, and community settings.
Continuing Education Information
This course is eligible for 2 CE credits through the SWEET Institute. Participants must attend the full duration and complete the post-seminar evaluation to receive credit.
Expected Outcomes
By the end of the seminar, participants will:
• Differentiate SAD from similar clinical presentations.
• Implement structured CBT and exposure interventions that dismantle safety behaviors.
• Integrate pharmacologic and digital modalities grounded in the latest empirical evidence.
• Apply measurement-based tools for assessment and relapse prevention.
